Accelerating progress towards the elimination of mother‐to‐child transmission of HIV: a narrative review

Findings from biomedical, behavioural and implementation studies provide a rich foundation to guide programmatic efforts for the prevention of mother‐to‐child HIV transmission (PMTCT).

[1]  B. Chi,et al.  Incident HIV among pregnant and breast-feeding women in sub-Saharan Africa: a systematic review and meta-analysis. , 2020, AIDS.

[2]  B. Chi,et al.  Incident HIV among pregnant and breastfeeding women in sub-Saharan Africa: a systematic review and meta-analysis. , 2020, AIDS (London).

[3]  L. Myer,et al.  Comparison of guidelines for HIV viral load monitoring among pregnant and breastfeeding women in sub-Saharan Africa: a simulation study. , 2020, AIDS.

[4]  C. Giaquinto,et al.  Reduced Time to Suppression Among Neonates With HIV Initiating Antiretroviral Therapy Within 7 Days After Birth. , 2019, Journal of acquired immune deficiency syndromes.

[5]  J. Baeten,et al.  Pre-exposure prophylaxis uptake and early continuation among pregnant and post-partum women within maternal and child health clinics in Kenya: results from an implementation programme. , 2019, The lancet. HIV.

[6]  D. Kuritzkes,et al.  Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile , 2019, Science Translational Medicine.

[7]  M. Weinstein,et al.  Cost-effectiveness of integrating postpartum antiretroviral therapy and infant care into maternal & child health services in South Africa , 2019, PloS one.

[8]  L. Myer,et al.  Long-term outcomes of HIV-infected women receiving antiretroviral therapy after transferring out of an integrated maternal and child health service in South Africa. , 2019, Journal of acquired immune deficiency syndromes.

[9]  B. Chi,et al.  The landscape for HIV pre-exposure prophylaxis during pregnancy and breastfeeding in Malawi and Zambia: A qualitative study , 2019, PloS one.

[10]  N. Ngandu,et al.  Longitudinal adherence to maternal antiretroviral therapy and infant Nevirapine prophylaxis from 6 weeks to 18 months postpartum amongst a cohort of mothers and infants in South Africa , 2019, BMC Infectious Diseases.

[11]  C. Yiannoutsos,et al.  Updates to the Spectrum/AIM model for estimating key HIV indicators at national and subnational levels , 2019, AIDS.

[12]  L. Berrie,et al.  Monitoring viral load for the last mile: what will it cost? , 2019, Journal of the International AIDS Society.

[13]  J. Baeten,et al.  Perinatal outcomes following maternal pre‐exposure prophylaxis (PrEP) use during pregnancy: results from a large PrEP implementation program in Kenya , 2019, Journal of the International AIDS Society.

[14]  Dorman Chimhamhiwa,et al.  Optimizing viral load testing access for the last mile: Geospatial cost model for point of care instrument placement , 2019, PloS one.

[15]  M. Onono,et al.  Acceptability of community-based mentor mothers to support HIV-positive pregnant women on antiretroviral treatment in western Kenya: a qualitative study , 2019, BMC Pregnancy and Childbirth.

[16]  E. Schouten,et al.  Impact of inter-partner HIV disclosure patterns in Malawi’s PMTCT program: A mixed-method study , 2019, PloS one.

[17]  S. Lockman,et al.  Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana. , 2019, The New England journal of medicine.

[18]  A. Amoah,et al.  Applying Quality Improvement Strategies to Health Services for HIV-Affected Mother–Baby Pairs in Rural Kenya , 2019, Journal of the International Association of Providers of AIDS Care.

[19]  L. Myer,et al.  Modelling the potential impact of providing preexposure prophylaxis in pregnant and breastfeeding women in South Africa. , 2019, AIDS.

[20]  G. Ramjee,et al.  Point-of-care HIV testing best practice for early infant diagnosis: an implementation study , 2019, BMC Public Health.

[21]  I. Mofolo,et al.  “I would love if there was a young woman to encourage us, to ease our anxiety which we would have if we were alone”: Adapting the Mothers2Mothers Mentor Mother Model for adolescent mothers living with HIV in Malawi , 2019, PloS one.

[22]  M. Pepper,et al.  An Early Infant HIV Risk Score for Targeted HIV Testing at Birth , 2019, Pediatrics.

[23]  Maria H. Kim,et al.  The HIV diagnostic assistant: early findings from a novel HIV testing cadre in Malawi , 2019, AIDS.

[24]  A. Moll,et al.  Perceptions of HIV Preexposure Prophylaxis Among Young Pregnant Women from Rural KwaZulu-Natal, South Africa. , 2019, AIDS patient care and STDs.

[25]  R. Burger,et al.  An Incentive-Based and Community Health Worker Package Intervention to Improve Early Utilization of Antenatal Care: Evidence from a Pilot Randomised Controlled Trial , 2019, Maternal and Child Health Journal.

[26]  Alison L. Drake,et al.  Retest and treat: a review of national HIV retesting guidelines to inform elimination of mother‐to‐child HIV transmission (EMTCT) efforts , 2019, Journal of the International AIDS Society.

[27]  Gabrielle E. O'Malley,et al.  PrEP Implementation for Mothers in Antenatal Care (PrIMA): study protocol of a cluster randomised trial , 2019, BMJ Open.

[28]  W. Fawzi,et al.  Community health workers to improve uptake of maternal healthcare services: A cluster-randomized pragmatic trial in Dar es Salaam, Tanzania , 2019, PLoS medicine.

[29]  G. Rutherford,et al.  Primary HIV prevention in pregnant and lactating Ugandan women: A randomized trial , 2019, PloS one.

[30]  J. Goudge,et al.  Impact of lay health worker programmes on the health outcomes of mother-child pairs of HIV exposed children in Africa: A scoping review , 2019, PloS one.

[31]  H. Bachou,et al.  Increasing HIV-Free Survival of Infants: Reorganizing Care Using Quality Improvement for the Optimal Health and Nutrition of HIV-Positive Women and Their Exposed Infants in Uganda , 2019, Journal of the International Association of Providers of AIDS Care.

[32]  A. Amoah,et al.  Engagement of National Stakeholders and Communities on Health-Care Quality Improvement: Experience from the Implementation of the Partnership for HIV-Free Survival in Tanzania , 2019, Journal of the International Association of Providers of AIDS Care.

[33]  C. Kilewo,et al.  Engaging community leaders to improve male partner participation in the prevention of mother-to-child transmission of HIV in Dar es Salaam, Tanzania , 2018, PloS one.

[34]  K. Goggin,et al.  “Closing the Gap”: Provider Recommendations for Implementing Birth Point of Care HIV Testing , 2018, AIDS and Behavior.

[35]  A. Abajobir,et al.  Does short message service improve focused antenatal care visit and skilled birth attendance? A systematic review and meta-analysis of randomized clinical trials , 2018, Reproductive Health.

[36]  R. Heffron,et al.  Global and national guidance for the use of pre-exposure prophylaxis during peri-conception, pregnancy and breastfeeding. , 2018, Sexual health.

[37]  D. Chege,et al.  Effectiveness of a Lay Counselor–Led Combination Intervention for Retention of Mothers and Infants in HIV Care: A Randomized Trial in Kenya , 2018, Journal of acquired immune deficiency syndromes.

[38]  Brenda N Onguti,et al.  Group versus individual antenatal and first year postpartum care: Study protocol for a multi-country cluster randomized controlled trial in Kenya and Nigeria. , 2018, Gates open research.

[39]  M. Davies,et al.  Neonatal and infant diagnostic HIV‐PCR uptake and associations during three sequential policy periods in Cape Town, South Africa: a longitudinal analysis , 2018, Journal of the International AIDS Society.

[40]  L. Cornelius,et al.  “They do not see us as one of them”: a qualitative exploration of mentor mothers’ working relationships with healthcare workers in rural North-Central Nigeria , 2018, Human Resources for Health.

[41]  D. Cohan.  ACOG Committee Opinion No. 752: Prenatal and Perinatal Human Immunodeficiency Virus Testing. , 2018, Obstetrics and gynecology.

[42]  J. Levison,et al.  Role of Preexposure Prophylaxis in the Reproductive Health of Women at Risk for Human Immunodeficiency Virus Infection. , 2018, Obstetrics and gynecology.

[43]  B. Södergård,et al.  Mentor Mothers Zithulele: exploring the role of a peer mentorship programme in rural PMTCT care in Zithulele, Eastern Cape, South Africa , 2018, Paediatrics and international child health.

[44]  L. Myer,et al.  Experiences of HIV-positive postpartum women and health workers involved with community-based antiretroviral therapy adherence clubs in Cape Town, South Africa , 2018, BMC Public Health.

[45]  R. Shapiro,et al.  Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception. , 2018, The New England journal of medicine.

[46]  J. Baeten,et al.  HIV-Uninfected Kenyan Adolescent and Young Women Share Perspectives on Using Preexposure Prophylaxis During Pregnancy. , 2018, AIDS patient care and STDs.

[47]  J. Baeten,et al.  Pregnancy outcomes and infant growth among babies with in utero exposure to tenofovir-based pre-exposure prophylaxis for HIV prevention. , 2018, AIDS.

[48]  G. John-Stewart.  eHealth and Prevention of Mother-to-Child Transmission of HIV , 2018, Current HIV/AIDS Reports.

[49]  S. Lockman,et al.  Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study , 2018, The Lancet. Global health.

[50]  M. Hughes,et al.  Targeted HIV testing at birth supported by low and predictable mother‐to‐child transmission risk in Botswana , 2018, Journal of the International AIDS Society.

[51]  Annie Neo Parsons,et al.  Mobile health messaging service and helpdesk for South African mothers (MomConnect): history, successes and challenges , 2018, BMJ Global Health.

[52]  L. Myer,et al.  Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial , 2018, PLoS medicine.

[53]  L. Mofenson,et al.  Piloting very early infant diagnosis of HIV in Lesotho: Acceptability and feasibility among mothers, health workers and laboratory personnel , 2018, PloS one.

[54]  J. Baeten,et al.  Maternal Tenofovir Disoproxil Fumarate Use During Pregnancy Is Not Associated With Adverse Perinatal Outcomes Among HIV-infected East African Women: A Prospective Study , 2017, The Journal of infectious diseases.

[55]  C. Cohen,et al.  Implementation of repeat HIV testing during pregnancy in southwestern Kenya: progress and missed opportunities , 2017, Journal of the International AIDS Society.

[56]  B. Chi,et al.  Involving both parents in HIV prevention during pregnancy and breastfeeding , 2017, Bulletin of the World Health Organization.

[57]  P. Barron,et al.  Introduction of Routine HIV Birth Testing in the South African National Consolidated Guidelines , 2017, The Pediatric infectious disease journal.

[58]  J. Baeten,et al.  “I Did Not Want to Give Birth to a Child Who has HIV”: Experiences Using PrEP During Pregnancy Among HIV-Uninfected Kenyan Women in HIV-Serodiscordant Couples , 2017, Journal of acquired immune deficiency syndromes.

[59]  Alana D. Steffen,et al.  Randomized controlled pilot of a group antenatal care model and the sociodemographic factors associated with pregnancy-related empowerment in sub-Saharan Africa , 2017, BMC Pregnancy and Childbirth.

[60]  L. Myer,et al.  Delivering preexposure prophylaxis to pregnant and breastfeeding women in Sub-Saharan Africa: the implementation science frontier. , 2017, AIDS.

[61]  S. Po‐Chedley,et al.  Distance to care, enrollment and loss to follow-up of HIV patients during decentralization of antiretroviral therapy in Neno District, Malawi: A retrospective cohort study , 2017, PloS one.

[62]  J. Nachega,et al.  Low HIV incidence in pregnant and postpartum women receiving a community-based combination HIV prevention intervention in a high HIV incidence setting in South Africa , 2017, PloS one.

[63]  M. Tanner,et al.  Prevention of mother-to-child transmission of HIV Option B+ cascade in rural Tanzania: The One Stop Clinic model , 2017, PloS one.

[64]  L. Myer,et al.  Differentiated models of care for postpartum women on antiretroviral therapy in Cape Town, South Africa: a cohort study , 2017, Journal of the International AIDS Society.

[65]  N. Tumwesigye,et al.  Prevention of mother-to-child transmission of HIV: Postpartum adherence to Option B+ until 18 months in Western Uganda , 2017, PloS one.

[66]  M. Fowler,et al.  Greater involvement of HIV-infected peer-mothers in provision of reproductive health services as “family planning champions” increases referrals and uptake of family planning among HIV-infected mothers , 2017, BMC Health Services Research.

[67]  E. Schouten,et al.  Impact of Facility- and Community-Based Peer Support Models on Maternal Uptake and Retention in Malawi's Option B+ HIV Prevention of Mother-to-Child Transmission Program: A 3-Arm Cluster Randomized Controlled Trial (PURE Malawi) , 2017, Journal of acquired immune deficiency syndromes.

[68]  H. Ramadhani,et al.  The Impact of Structured Mentor Mother Programs on 6-Month Postpartum Retention and Viral Suppression among HIV-Positive Women in Rural Nigeria: A Prospective Paired Cohort Study , 2017, Journal of Acquired Immune Deficiency Syndromes.

[69]  J. Yeon,et al.  Systematic review with meta‐analysis: the efficacy and safety of tenofovir to prevent mother‐to‐child transmission of hepatitis B virus , 2017, Alimentary pharmacology & therapeutics.

[70]  Arjan de Wagt,et al.  Integration of HIV Testing into Maternal, Newborn, and Child Health Weeks for Improved Case Finding and Linkage to Prevention of Mother-to-Child Transmission Services in Benue State, Nigeria , 2017, Front. Public Health.

[71]  D. Cohan,et al.  Offering pre-exposure prophylaxis for HIV prevention to pregnant and postpartum women: a clinical approach , 2017, Journal of the International AIDS Society.

[72]  L. Mofenson,et al.  Tenofovir disoproxil fumarate safety for women and their infants during pregnancy and breastfeeding , 2017, AIDS.

[73]  Jennifer A. Unger,et al.  A Risk Assessment Tool for Identifying Pregnant and Postpartum Women Who May Benefit From Preexposure Prophylaxis , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[74]  S. Maman,et al.  Promoting Partner Testing and Couples Testing through Secondary Distribution of HIV Self-Tests: A Randomized Clinical Trial , 2016, PLoS medicine.

[75]  L. Mofenson,et al.  Improving estimates of children living with HIV from the Spectrum AIDS Impact Model , 2016, AIDS.

[76]  G. John-Stewart,et al.  Male Partner Participation in Antenatal Clinic Services is Associated With Improved HIV-Free Survival Among Infants in Nairobi, Kenya: A Prospective Cohort Study , 2016, Journal of acquired immune deficiency syndromes.

[77]  M. Egger,et al.  Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's Option B+ Program , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[78]  J. Gallant,et al.  Antiretroviral Therapy for the Prevention of HIV-1 Transmission. , 2016, The New England journal of medicine.

[79]  R. Grant,et al.  Effectiveness and safety of oral HIV preexposure prophylaxis for all populations , 2016, AIDS.

[80]  J. Wasserheit,et al.  Impact of a Systems Engineering Intervention on PMTCT Service Delivery in Côte d’Ivoire, Kenya, Mozambique: A Cluster Randomized Trial , 2016 .

[81]  J. Kinuthia,et al.  Home-Based HIV Testing Among Pregnant Couples Increases Partner Testing and Identification of Serodiscordant Partnerships , 2016, Journal of acquired immune deficiency syndromes.

[82]  J. Kinuthia,et al.  Modeling the Cost-Effectiveness of Home-Based HIV Testing and Education (HOPE) for Pregnant Women and Their Male Partners in Nyanza Province, Kenya , 2016, Journal of acquired immune deficiency syndromes.

[83]  S. Maman,et al.  Promoting male partner HIV testing and safer sexual decision making through secondary distribution of self-tests by HIV-negative female sex workers and women receiving antenatal and post-partum care in Kenya: a cohort study. , 2016, The lancet. HIV.

[84]  A. Jahn,et al.  Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study. , 2016, The lancet. HIV.

[85]  R. Heffron,et al.  PrEP as Peri-conception HIV Prevention for Women and Men , 2016, Current HIV/AIDS Reports.

[86]  E. Livingston,et al.  Integrase inhibitors in late pregnancy and rapid HIV viral load reduction. , 2016, American journal of obstetrics and gynecology.

[87]  S. Vermund,et al.  Engagement of Men in Antenatal Care Services: Increased HIV Testing and Treatment Uptake in a Community Participatory Action Program in Mozambique , 2016, AIDS and Behavior.

[88]  A. Harries,et al.  Same day HIV diagnosis and antiretroviral therapy initiation affects retention in Option B+ prevention of mother-to-child transmission services at antenatal care in Zomba District, Malawi , 2016, Journal of the International AIDS Society.

[89]  J. Mandala,et al.  A systematic review of interventions to improve prevention of mother-to-child HIV transmission service delivery and promote retention , 2016, Journal of the International AIDS Society.

[90]  S. Till,et al.  Incentives for increasing prenatal care use by women in order to improve maternal and neonatal outcomes. , 2015, The Cochrane database of systematic reviews.

[91]  Julie M. Herlihy,et al.  Implementation and Operational Research: Integration of PMTCT and Antenatal Services Improves Combination Antiretroviral Therapy Uptake for HIV-Positive Pregnant Women in Southern Zambia: A Prototype for Option B+? , 2015, Journal of acquired immune deficiency syndromes.

[92]  B. Chi,et al.  Implementation and Operational Research: Distance From Household to Clinic and Its Association With the Uptake of Prevention of Mother-to-Child HIV Transmission Regimens in Rural Zambia , 2015, Journal of acquired immune deficiency syndromes.

[93]  J. Pharr,et al.  Effect of a congregation-based intervention on uptake of HIV testing and linkage to care in pregnant women in Nigeria (Baby Shower): a cluster randomised trial. , 2015, The Lancet. Global health.

[94]  S. Shade,et al.  Implementation and Operational Research: Effects of Antenatal Care and HIV Treatment Integration on Elements of the PMTCT Cascade: Results From the SHAIP Cluster-Randomized Controlled Trial in Kenya. , 2015, Journal of acquired immune deficiency syndromes.

[95]  P. Barker,et al.  The role of quality improvement in achieving effective large-scale prevention of mother-to-child transmission of HIV in South Africa , 2015, AIDS.

[96]  R. Gangakhedkar,et al.  Cost-effectiveness of a repeat HIV test in pregnancy in India , 2015, BMJ Open.

[97]  N. Shaffer,et al.  Impact of Maternal HIV Seroconversion during Pregnancy on Early Mother to Child Transmission of HIV (MTCT) Measured at 4-8 Weeks Postpartum in South Africa 2011-2012: A National Population-Based Evaluation , 2015, PloS one.

[98]  A. Pettifor,et al.  Acceptability and Feasibility of a Mobile Phone-Based Case Management Intervention to Retain Mothers and Infants from an Option B+ Program in Postpartum HIV Care , 2015, Maternal and Child Health Journal.

[99]  W. Fawzi,et al.  Community Health Workers to Improve Antenatal Care and PMTCT Uptake in Dar es Salaam, Tanzania: A Quantitative Performance Evaluation , 2014, Journal of acquired immune deficiency syndromes.

[100]  D. Wamalwa,et al.  PO-0260a Efficacy Of Mobile Phone Use On Adherence To Nevirapine Prophylaxis And Retention In Care Among The Hiv-exposed Infants In Pmtct: A Randomised Controlled Trial , 2014, Archives of Disease in Childhood.

[101]  H. Weiss,et al.  Systematic review of strategies to increase men's HIV-testing in sub-Saharan Africa , 2014, AIDS.

[102]  J. Baeten,et al.  Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial. , 2014, JAMA.

[103]  Alison L. Drake,et al.  Incident HIV during Pregnancy and Postpartum and Risk of Mother-to-Child HIV Transmission: A Systematic Review and Meta-Analysis , 2014, PLoS medicine.

[104]  P. Barron,et al.  Elimination of mother-to-child transmission of HIV in South Africa: rapid scale-up using quality improvement. , 2014, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[105]  B. Richardson,et al.  Home visits during pregnancy enhance male partner HIV counselling and testing in Kenya: a randomized clinical trial , 2014, AIDS.

[106]  F. Taziwa,et al.  Mother to Mother (M2M) Peer Support for Women in Prevention of Mother to Child Transmission (PMTCT) Programmes: A Qualitative Study , 2013, PloS one.

[107]  A. Caughey,et al.  The Cost-Effectiveness of Repeat HIV Testing During Pregnancy in a Resource-Limited Setting , 2013, Journal of acquired immune deficiency syndromes.

[108]  K. Peltzer,et al.  Reducing the risk of HIV infection during pregnancy among South African women: A randomized controlled trial , 2013, AIDS care.

[109]  W. Fawzi,et al.  Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial , 2012, The Lancet.

[110]  Lei Wang,et al.  Prevention of HIV-1 infection with early antiretroviral therapy. , 2011, The New England journal of medicine.

[111]  B. Richardson,et al.  Male Antenatal Attendance and HIV Testing Are Associated With Decreased Infant HIV Infection and Increased HIV-Free Survival , 2011, Journal of acquired immune deficiency syndromes.

[112]  W. Comulada,et al.  Mamekhaya: a pilot study combining a cognitive-behavioral intervention and mentor mothers with PMTCT services in South Africa , 2010, AIDS care.

[113]  Michael G Hudgens,et al.  Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. , 2010, The New England journal of medicine.

[114]  J. Stringer,et al.  Antiretroviral therapy in antenatal care to increase treatment initiation in HIV-infected pregnant women: a stepped-wedge evaluation , 2010, AIDS.

[115]  James A McIntyre,et al.  Early antiretroviral therapy and mortality among HIV-infected infants. , 2008, The New England journal of medicine.

[116]  Y. Maldonado,et al.  The feasibility of preventing mother-to-child transmission of HIV using peer counselors in Zimbabwe , 2008, AIDS research and therapy.

[117]  L. Moulton,et al.  Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials , 2008, The Lancet.

[118]  L. Mofenson,et al.  Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. , 2008, The New England journal of medicine.

[119]  B. Richardson,et al.  Antenatal Couple Counseling Increases Uptake of Interventions to Prevent HIV-1 Transmission , 2004, Journal of acquired immune deficiency syndromes.

[120]  KEY CONSIDERATIONS FOR PROGRAMMING AND PRIORITIZATION , 2020 .

[121]  N. Siegfried,et al.  GUIDELINES ON HIV SELF-TESTING AND PARTNER NOTIFICATION , 2017 .